Effect of irradiation on bromodeoxyuridine incorporation in human colon cancer xenografts

International Journal of Radiation Oncology Biology Physics

Volumn 34, Issue 3, 1996, Pages 617-621

  Lawrence, Theodore S ^a   Chang, Emily Y ^a   Davis, Mary A ^a   Stetson, Philip L ^a   Ensminger, William D ^a,b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Bromodeoxyuridine; Human tumor xenografts; Nucleoside analogs; Radiation sensitizers

Indexed keywords

BROXURIDINE; THYMIDINE DERIVATIVE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GRAFT; CANCER INHIBITION; CANCER RADIOTHERAPY; COLON CANCER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; RADIATION DOSE; RADIOSENSITIVITY; XENOGRAFT;

EID: 0030066442     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/0360-3016(95)02117-5     Document Type: Article

References (21)

1. Beisker, W.; Dolbeare, F.; Gray, J. W. An improved immunocytochemical procedure for high sensitivity detection of incorporated bromodeoxyuridine. Cytometry 8:235-239; 1987.
2. Chang, A. E.; Collins, J. M.; Speth, P. A. J., Smith, R.; Rowland J. B.; Waltom, L.; Begley, M. G.; Glatstein, E.; Kinsella, T. J. A phase I study of intraarterial iododeoxyuridine in patients with colorectal liver metastases. J. Clin. Oncol. 7:662-668; 1989.
3. 125-labeled iododeoxyuridine into the deoxyribonucleic acid of murine and human tissues following therapeutic doses. Cancer Res. 23:1715-1723; 1963.
4. Hegarty, T. J.; Thornton, A. F.; Diaz, R. F.; Chandler, W. F.; Ensminger, W. D.; Junck, L.; Page, M. A.; Gebarski, S. S.; Hood, T. W.; Stetson, P. L. Intra-arterial bromodeoxyuridine radiosensitization of malignant gliomas. Int. J. Radiat. Oncol. Biol. Phys. 19(2):421-428; 1990.
5. Knol, J. A.; Walker, S. C.; Robertson, J. M.; Yang, Z.; DeRemer, S.; Stetson, P. L.; Ensminger, W. D.; Lawrence, T. S. Incorporation of 5-Bromo-2′-deoxyuridine into colorectal liver metastases and liver in patients receiving a 7-day hepatic arterial infusion. Cancer Res. 55:3687-3691; 1995.
6. Lawrence, T. S.; Davis, M. A.; Stetson, P. L.; Maybaum, J.; Ensminger, W. D. Kinetics of bromodeoxyuridine elimination from human colon cancer cells in vitro and in vivo. Cancer Res. 54(11):2964-2968; 1994.
7. Lawrence, T. S.; Davis, M. A.; McKeever, P. E.; Maybaum, J.; Stetson, P. L. Normolle, D. P.; Ensminger, W. D. Fluorodeoxyuridine-mediated modulation of iododeoxyuridine incorporation and radiosensitization in human colon cancer cells in vitro and in vivo. Cancer Res. 51(15):3900-3905; 1991.
8. Lawrence, T. S.; Davis, M. A.; Maybaum, J.; Mukhopadhyay, S. K.; Stetson, P. L.; Normolle, D. P.; McKeever, P. E.; Ensminger, W. D. The potential superiority of bromodeoxyuridine to iododeoxyuridine as a radiation sensitizer in the treatment of colorectal cancer. Cancer Res. 52:3698-3704; 1992.
9. Maybaum, J.; Kott, M. G.; Johnson, N. J.; Ensminger, W. D.; Stetson, P. L. Analysis of bromodeoxyuridine incorporation into DNA: Comparison of gas Chromatographic/ mass spectrometric, CsCl gradient sedimentation, and specific radioactivity methods. Anal. Biochem. 161(1):164-171; 1987.
10. McKeever, P. E.; Letica, L. H.; Shakui, P.; Averill, D. R. A multiple-well method for immunohistochemical testing of many reagents on a single microscopic slide. Lab. Invest. 59: 409-413; 1988.
11. Painter, R. B.; Young, B. R. Radiosensitivity in ataxiatelangiectasia: A new explanation. Proc. Natl. Acad. Sci. USA 77:7315-7317; 1980.
12. Phillips, T. L.; Leven, V. A.; Ahn, D. K.; Gutin, P. H.; Davis, R. L.; Wilson, C. B.; Prados, M. D.; Wara, W. M.; Flam, M. S. Evaluation of bromodeoxyuridine in glioblastoma multiforme: A Northern California Cancer Center phase II study. Int. J. Radiat. Oncol. Biol. Phys. 21:709-714; 1991.
13. Robertson, J. M.; Sondak, V. K.; Weiss, S. A.; Sussman, J. J.; Chang, A. E.; Lawrence, T. S. Preoperative radiation therapy and iododeoxyuridine for large retroperitoneal sarcomas. Int. J. Radiat. Oncol. Biol. Phys. 31:87-92; 1995.
14. Robertson, J. M.; Johnson, D.; Eisbruch, A.; Reynolds, K.; Roberts, J.; Lawrence, T. S. A phase I/TI study of bromodeoxyuridine (BrdU) and radiation therapy (RT) for locally advanced cervix cancer. Proc. ASCO 14:201; 1995.
15. Rodriguez, R.; Miller, E.; Fowler, J. F.; Kinsella, T. J. Continuous infusion of halogenated pyrimidines. (Correspondence). Int. J. Radiat. Oncol. Biol. Phys. 20:1378; 1991.
16. Rodriguez, R.; Ritter, M. A.; Fowler, J. F.; Kinsella, T. J. Kinetics of cell labeling and thymidine replacement after continuous infusion of halogenated pyrimidines in vivo. Int. J. Radiat. Oncol. Biol. Phys. 29:105-113; 1994.
17. 131I in spontaneous C3H mouse mammary tumours. Br. J. Radiol. 35:337-342; 1962.
18. Stetson, P. L.; Maybaum, J.; Shukla, U. A.; Ensminger, W. D. Simultaneous determination of thymine and 5-bromouracil in DNA hydrolysates using gas chromatographymass spectrometry with selected-ion monitoring. J. Chromatogr. 375:1-9; 1986.
19. Sullivan, F. J.; Herscher, L. L.; Cook, J. A.; Smith, J.; Steinberg, S. M.; Epstein, A. H.; Oldfield, E. H.; Goffman, T. E.; Kinsella, T. J.; Mitchell, J.; Glatstein, E. National Cancer Institute (Phase II) study of high-grade glioma treated with accelerated hyperfractionated radiation and iododeoxyuridine: results in anaplastic astrocytoma. Int. J. Radiat. Oncol. Biol. Phys. 30:583-590; 1994.
20. Tolmach, L. J.; Jones, R. W.; Busse, P. M. The action of caffeine on X-irradiated HeLa cells. I. Delayed inhibition of DNA synthesis. Radiat. Res. 71:653-665; 1977.
21. Weinert, T. A.; Hartwell, L. H. The RAD9 gene controls the cell cycle response to DNA damage in Saccharomyces cerevisiae. Science 241:317-322; 1988.